Insufficient scRNA-seq data for expression of CERS1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2488.91 | 2640 / 2642 | 100% | 41.76 | 702 / 705 |
eye | 0% | 0 | 0 / 0 | 100% | 24.09 | 80 / 80 |
skin | 0% | 0 | 0 / 1809 | 87% | 10.35 | 410 / 472 |
adrenal gland | 3% | 9.69 | 8 / 258 | 65% | 7.41 | 149 / 230 |
prostate | 2% | 3.95 | 4 / 245 | 29% | 1.41 | 145 / 502 |
thymus | 0% | 0.60 | 2 / 653 | 28% | 1.02 | 167 / 605 |
bladder | 14% | 31.05 | 3 / 21 | 8% | 0.38 | 39 / 504 |
uterus | 1% | 2.79 | 2 / 170 | 17% | 1.50 | 78 / 459 |
ovary | 7% | 26.09 | 12 / 180 | 10% | 0.36 | 45 / 430 |
muscle | 12% | 30.20 | 96 / 803 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 10% | 1.13 | 18 / 178 |
liver | 0% | 0 | 0 / 226 | 8% | 0.40 | 34 / 406 |
breast | 0% | 0.45 | 1 / 459 | 6% | 0.27 | 67 / 1118 |
intestine | 5% | 13.63 | 44 / 966 | 1% | 0.06 | 5 / 527 |
heart | 5% | 13.56 | 47 / 861 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 5% | 0.24 | 43 / 901 |
lung | 0% | 0 | 0 / 578 | 5% | 0.21 | 53 / 1155 |
esophagus | 2% | 5.12 | 28 / 1445 | 2% | 0.06 | 4 / 183 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
stomach | 1% | 1.89 | 3 / 359 | 1% | 0.03 | 3 / 286 |
blood vessel | 1% | 2.09 | 9 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.32 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0072721 | Biological process | cellular response to dithiothreitol |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0051974 | Biological process | negative regulation of telomerase activity |
GO_0071492 | Biological process | cellular response to UV-A |
GO_0036146 | Biological process | cellular response to mycotoxin |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_1901526 | Biological process | positive regulation of mitophagy |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0050291 | Molecular function | sphingosine N-acyltransferase activity |
Gene name | CERS1 |
Protein name | Ceramide synthase 1 Ceramide synthase 1 (CerS1) (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299) Ceramide synthase 1 (LASS1 protein) |
Synonyms | LASS1 UOG1 LAG1 |
Description | FUNCTION: Ceramide synthase that catalyzes the transfer of the acyl chain from acyl-CoA to a sphingoid base, with high selectivity toward stearoyl-CoA (octadecanoyl-CoA; C18:0-CoA) . N-acylates sphinganine and sphingosine bases to form dihydroceramides and ceramides in de novo synthesis and salvage pathways, respectively . Plays a predominant role in skeletal muscle in regulating C18 ceramide and dihydroceramide levels with an impact on whole-body glucose metabolism and insulin sensitivity. Protects from diet-induced obesity by suppressing the uptake of glucose in multiple organs in a FGF21-dependent way (By similarity). Generates C18 ceramides in the brain, playing a critical role in cerebellar development and Purkinje cell function (By similarity). In response to cellular stress mediates mitophagy, a known defense mechanism against cell transformation and aging. Upon mitochondria fission, generates C18 ceramides that anchor lipidated MAP1LC3B/LC3B-II autophagolysosomes to outer mitochondrial membranes to eliminate damaged mitochondria . . |
Accessions | ENST00000429504.6 [P27544-2] ENST00000623882.4 [P27544-1] P27544 ENST00000596048.1 Q5XG75 M0R0T2 ENST00000542296.6 |